FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113170028> ?p ?o ?g. }

• W3113170028 endingPage "100129" @default.
• W3113170028 startingPage "100129" @default.
• W3113170028 abstract "The optimal management of large cell neuroendocrine cancer of the lung (LCNEC) is unclear, and data regarding anti-programmed cell death protein 1 (PD-1) antibodies are scarce. This study reports the clinical efficacy of a PD-1 inhibitor in patients with advanced LCNEC.All patients with stage III to IV LCNEC treated with at least one previous cycle of chemotherapy between January 1, 2015 and December 31, 2018 were reviewed retrospectively. Patients were divided into two groups depending on their exposure to nivolumab as second-line treatment or beyond. The primary objective was to assess nivolumab's efficacy.A total of 51 patients with advanced LCNEC from eight centers were analyzed, including 17 who received nivolumab. The PD-1 inhibitor was used as second-line treatment in 77% of cases, with a median number of eight doses (range: 1-62). After nivolumab treatment, the median overall survival was 12.1 months (95% confidence interval [CI]: 7.10-14.20). The objective response rate was 29.4% (95% CI: 10.3-56.0), and median progression-free survival was 3.9 months (95% CI: 1.68-7.17). The programmed death-ligand 1 status was unknown. There was no difference in the efficacy of first-line chemotherapy; the objective response rate was 23.5% (n = four of 17) in the nivolumab group versus 32.4% (n = 11 of 34) in the conventional treatment group, and progression-free survival was 3.5 months (95% CI: 1.7-4.4) versus 2.1 months (95% CI: 1.4-4.2), respectively.In a real-world setting, nivolumab seems to be an effective second-line treatment in patients with advanced LCNEC. Large prospective studies in this setting are still required." @default.
• W3113170028 created "2020-12-21" @default.
• W3113170028 creator A5000960681 @default.
• W3113170028 creator A5015766588 @default.
• W3113170028 creator A5032332349 @default.
• W3113170028 creator A5033220886 @default.
• W3113170028 creator A5035722823 @default.
• W3113170028 creator A5038690429 @default.
• W3113170028 creator A5040900859 @default.
• W3113170028 creator A5042369527 @default.
• W3113170028 creator A5053117625 @default.
• W3113170028 creator A5054700332 @default.
• W3113170028 creator A5073155356 @default.
• W3113170028 date "2021-04-01" @default.
• W3113170028 modified "2023-10-15" @default.
• W3113170028 title "Brief Report on the Efficacy of Nivolumab in Patients With Previously Treated Advanced Large-Cell Neuroendocrine Cancer of the Lung" @default.
• W3113170028 cites W1973610279 @default.
• W3113170028 cites W1988620211 @default.
• W3113170028 cites W2104347254 @default.
• W3113170028 cites W2125665528 @default.
• W3113170028 cites W2156353875 @default.
• W3113170028 cites W2158254448 @default.
• W3113170028 cites W2251438188 @default.
• W3113170028 cites W2262621604 @default.
• W3113170028 cites W2569525929 @default.
• W3113170028 cites W2572174216 @default.
• W3113170028 cites W2603972544 @default.
• W3113170028 cites W2754983509 @default.
• W3113170028 cites W2765973383 @default.
• W3113170028 cites W2801356307 @default.
• W3113170028 cites W2902858494 @default.
• W3113170028 cites W647594952 @default.
• W3113170028 doi "https://doi.org/10.1016/j.jtocrr.2020.100129" @default.
• W3113170028 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8474479" @default.
• W3113170028 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34590004" @default.
• W3113170028 hasPublicationYear "2021" @default.
• W3113170028 type Work @default.
• W3113170028 sameAs 3113170028 @default.
• W3113170028 citedByCount "3" @default.
• W3113170028 countsByYear W31131700282021 @default.
• W3113170028 countsByYear W31131700282022 @default.
• W3113170028 crossrefType "journal-article" @default.
• W3113170028 hasAuthorship W3113170028A5000960681 @default.
• W3113170028 hasAuthorship W3113170028A5015766588 @default.
• W3113170028 hasAuthorship W3113170028A5032332349 @default.
• W3113170028 hasAuthorship W3113170028A5033220886 @default.
• W3113170028 hasAuthorship W3113170028A5035722823 @default.
• W3113170028 hasAuthorship W3113170028A5038690429 @default.
• W3113170028 hasAuthorship W3113170028A5040900859 @default.
• W3113170028 hasAuthorship W3113170028A5042369527 @default.
• W3113170028 hasAuthorship W3113170028A5053117625 @default.
• W3113170028 hasAuthorship W3113170028A5054700332 @default.
• W3113170028 hasAuthorship W3113170028A5073155356 @default.
• W3113170028 hasBestOaLocation W31131700281 @default.
• W3113170028 hasConcept C121608353 @default.
• W3113170028 hasConcept C126322002 @default.
• W3113170028 hasConcept C143998085 @default.
• W3113170028 hasConcept C2776256026 @default.
• W3113170028 hasConcept C2776694085 @default.
• W3113170028 hasConcept C2777701055 @default.
• W3113170028 hasConcept C2780030458 @default.
• W3113170028 hasConcept C44249647 @default.
• W3113170028 hasConcept C71924100 @default.
• W3113170028 hasConcept C90924648 @default.
• W3113170028 hasConceptScore W3113170028C121608353 @default.
• W3113170028 hasConceptScore W3113170028C126322002 @default.
• W3113170028 hasConceptScore W3113170028C143998085 @default.
• W3113170028 hasConceptScore W3113170028C2776256026 @default.
• W3113170028 hasConceptScore W3113170028C2776694085 @default.
• W3113170028 hasConceptScore W3113170028C2777701055 @default.
• W3113170028 hasConceptScore W3113170028C2780030458 @default.
• W3113170028 hasConceptScore W3113170028C44249647 @default.
• W3113170028 hasConceptScore W3113170028C71924100 @default.
• W3113170028 hasConceptScore W3113170028C90924648 @default.
• W3113170028 hasFunder F4320307115 @default.
• W3113170028 hasFunder F4320307770 @default.
• W3113170028 hasFunder F4320307779 @default.
• W3113170028 hasFunder F4320332932 @default.
• W3113170028 hasIssue "4" @default.
• W3113170028 hasLocation W31131700281 @default.
• W3113170028 hasLocation W311317002810 @default.
• W3113170028 hasLocation W31131700282 @default.
• W3113170028 hasLocation W31131700283 @default.
• W3113170028 hasLocation W31131700284 @default.
• W3113170028 hasLocation W31131700285 @default.
• W3113170028 hasLocation W31131700286 @default.
• W3113170028 hasLocation W31131700287 @default.
• W3113170028 hasLocation W31131700288 @default.
• W3113170028 hasLocation W31131700289 @default.
• W3113170028 hasOpenAccess W3113170028 @default.
• W3113170028 hasPrimaryLocation W31131700281 @default.
• W3113170028 hasRelatedWork W2478002927 @default.
• W3113170028 hasRelatedWork W2800160190 @default.
• W3113170028 hasRelatedWork W2890849069 @default.
• W3113170028 hasRelatedWork W2898986397 @default.
• W3113170028 hasRelatedWork W2947988614 @default.
• W3113170028 hasRelatedWork W2976744492 @default.
• W3113170028 hasRelatedWork W2981652925 @default.

• next